Johnson & Johnson (JNJ) EPS (Basic) (QoQ) (2009 - 2026)
Johnson & Johnson (JNJ) EPS (Basic) (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.97 Bn | 633.21 Bn | 17.26 Bn |
| 2 | AbbVie | 470.43 Bn | 463.86 Bn | 12.70 Bn |
| 3 | Merck | 376.87 Bn | 369.73 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.36 Bn | 295.67 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.56 Bn | 252.66 Bn | 12.86 Bn |
| 6 | Amgen | 236.76 Bn | 222.77 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.01 Bn | 178.83 Bn | 6.22 Bn |
| 8 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn |
| 9 | Gsk | 106.08 Bn | 101.91 Bn | 8.24 Bn |
| 10 | Sanofi | 55.09 Bn | 47.71 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 5.77% |
| Mar 29, 2026 | 2.27% |
| Dec 28, 2025 | -0.66% |
| Sep 28, 2025 | -7.03% |
| Jun 29, 2025 | -49.64% |
| Dec 31, 2023 | -100.38% |
| Oct 1, 2023 | 9,741.79% |
| Jul 2, 2023 | -155.00% |
| Apr 2, 2023 | 45.46% |
| Jan 1, 2023 | 98.18% |
| Oct 2, 2022 | -73.17% |
| Jul 3, 2022 | -4.51% |
| Oct 3, 2021 | -41.59% |
| Jul 4, 2021 | 1.27% |
| Apr 4, 2021 | 256.72% |
| Jan 3, 2021 | -51.10% |
| Sep 27, 2020 | -1.97% |
| Jun 28, 2020 | -37.42% |
| Mar 29, 2020 | 45.16% |
| Dec 29, 2019 | 127.89% |